Download this Fact Sheet as a 81KB PDF
The Biden-Harris Administration launched a new nationwide Test to Treat initiative in March 2022 to give individuals another important way to quickly access free lifesaving treatment for COVID-19. Through this program, people are able to get tested, receive a prescription for oral antivirals, and when appropriate as determined by a health care provider, have their prescription filled all at one location. People can also continue to be tested and treated by their own health care providers, healthcare clinics in their community, and telehealth providers who can appropriately prescribe the oral antivirals to locations where the medicines are distributed. The “One-Stop Test to Treat” sites are already available at thousands of locations nationwide, including pharmacy-based clinics, federally-funded health centers, long-term care facilities, and community-based sites.
Beginning in May, new federally-supported Test-to-Treat locations are available to build on existing Test-to-Treat networks by focusing on reaching hard-hit and high-risk communities and ensuring equitable access to lifesaving COVID-19 treatments.
To help ensure the federally-supported Test to Treat sites program remains focused on reaching hard-hit and high-risk underserved populations and achieving equitable access to COVID-19 oral antiviral therapeutics, the following elements should exist at all federally-supported Test to Treat locations:
- End-to-end testing, linkage to healthcare provider visit, and medication dispensing, available on-site, enabling a seamless patient experience
- Services provided to all individuals, regardless of insurance status
- Patients accepted for priority same-day or next-day visits
- All services provided at no charge to the patient
- Site located in area with mid to high social vulnerability index (>0.50)
- Surrounding county/parish includes large racial or ethnic minority population
- Prioritization given to sites in locations with current medium to high community level
- Prioritization given to locations with limited number of Test to Treat sites within a 20-mile radius
For more information on the Test to Treat initiative, visit
aspr.hhs.gov.
